| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.629 | 5.143 | 26.756 | 30.569 | 32.140 | 45.313 | 47.584 | 44.975 | 44.206 |
| Total Income - EUR | - | 1.629 | 5.287 | 26.757 | 30.570 | 32.144 | 45.514 | 47.589 | 44.976 | 44.207 |
| Total Expenses - EUR | - | 2.311 | 6.113 | 10.232 | 11.735 | 16.079 | 15.265 | 14.480 | 21.312 | 19.161 |
| Gross Profit/Loss - EUR | - | -682 | -826 | 16.525 | 18.836 | 16.065 | 30.249 | 33.109 | 23.664 | 25.046 |
| Net Profit/Loss - EUR | - | -731 | -905 | 16.258 | 18.530 | 15.759 | 29.992 | 32.633 | 23.214 | 23.719 |
| Employees | - | 0 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Respilife Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 8.824 | 12.337 | 11.838 | 16.368 | 15.706 | 15.042 | 14.224 | 12.498 | 11.365 |
| Current Assets | - | 790 | 4.187 | 12.080 | 27.241 | 32.173 | 34.609 | 21.552 | 15.892 | 13.873 |
| Inventories | - | 383 | 1.364 | 1.811 | 1.943 | 3.558 | 3.849 | 5.186 | 2.898 | 3.477 |
| Receivables | - | 334 | 0 | 1.593 | 3.883 | 3.944 | 6.650 | 4.658 | 7.400 | 1.810 |
| Cash | - | 73 | 2.823 | 8.676 | 21.415 | 24.671 | 24.110 | 11.707 | 5.594 | 8.585 |
| Shareholders Funds | - | -687 | -1.581 | 14.706 | 32.951 | 17.075 | 46.689 | 32.828 | 23.295 | 23.806 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 10.300 | 18.105 | 9.212 | 10.658 | 30.804 | 2.963 | 2.948 | 5.096 | 1.433 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Respilife Srl